Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Sorting of soluble TNF-receptor for granule storage in hematopoietic cells as a principle for targeting of selected proteins to inflamed sites.

Gao, Ying LU ; Rosén, Hanna LU ; Johnsson, Ellinor ; Calafat, Jero ; Tapper, Hans LU and Olsson, Inge LU (2003) In Blood 102(2). p.682-688
Abstract
Hematopoietic cells have secretory lysosomes that degranulate at the inflammatory site upon stimulation. We asked whether one could target exogenous proteins with a therapeutic potential to secretory lysosomes in hematopoietic cells. For this purpose, we expressed a soluble tumor necrosis factor (TNF) receptor form (sTNFR1) in hematopoietic cell lines. In order to accomplish targeting to secretory lysosomes, both endoplasmic reticulum (ER) retention and constitutive secretion have to be prevented. ER export was facilitated by addition of a transmembrane (tm) sequence, and constitutive secretion was overcome by incorporating a cytosolic sorting signal (Y) from CD63. This signal directed the resulting sTNFR1-tm-Y to secretory lysosomes.... (More)
Hematopoietic cells have secretory lysosomes that degranulate at the inflammatory site upon stimulation. We asked whether one could target exogenous proteins with a therapeutic potential to secretory lysosomes in hematopoietic cells. For this purpose, we expressed a soluble tumor necrosis factor (TNF) receptor form (sTNFR1) in hematopoietic cell lines. In order to accomplish targeting to secretory lysosomes, both endoplasmic reticulum (ER) retention and constitutive secretion have to be prevented. ER export was facilitated by addition of a transmembrane (tm) sequence, and constitutive secretion was overcome by incorporating a cytosolic sorting signal (Y) from CD63. This signal directed the resulting sTNFR1-tm-Y to secretory lysosomes. Confirmation of these results was provided by biosynthetic radiolabeling, subcellular fractionation, immunofluorescence microscopy, and immunoelectron microscopy. The tm-Y fragment was cleaved by proteolysis, resulting in generation of the membrane-free sTNFR1 in secretory lysosomes. Our results suggest a potential for using the storage organelles of hematopoietic cells as vehicles for targeting sites of inflammation with therapeutically active agents. (C) 2003 by The American Society of Hematology. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Blood
volume
102
issue
2
pages
682 - 688
publisher
American Society of Hematology
external identifiers
  • wos:000184083500048
  • scopus:0038156161
  • pmid:12649164
ISSN
1528-0020
DOI
10.1182/blood-2002-10-3055
language
English
LU publication?
yes
id
fe15660a-0d7f-494c-bfc3-c563ed15d5b9 (old id 112646)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12649164&dopt=Abstract
date added to LUP
2016-04-01 12:07:38
date last changed
2022-01-26 23:08:38
@article{fe15660a-0d7f-494c-bfc3-c563ed15d5b9,
  abstract     = {{Hematopoietic cells have secretory lysosomes that degranulate at the inflammatory site upon stimulation. We asked whether one could target exogenous proteins with a therapeutic potential to secretory lysosomes in hematopoietic cells. For this purpose, we expressed a soluble tumor necrosis factor (TNF) receptor form (sTNFR1) in hematopoietic cell lines. In order to accomplish targeting to secretory lysosomes, both endoplasmic reticulum (ER) retention and constitutive secretion have to be prevented. ER export was facilitated by addition of a transmembrane (tm) sequence, and constitutive secretion was overcome by incorporating a cytosolic sorting signal (Y) from CD63. This signal directed the resulting sTNFR1-tm-Y to secretory lysosomes. Confirmation of these results was provided by biosynthetic radiolabeling, subcellular fractionation, immunofluorescence microscopy, and immunoelectron microscopy. The tm-Y fragment was cleaved by proteolysis, resulting in generation of the membrane-free sTNFR1 in secretory lysosomes. Our results suggest a potential for using the storage organelles of hematopoietic cells as vehicles for targeting sites of inflammation with therapeutically active agents. (C) 2003 by The American Society of Hematology.}},
  author       = {{Gao, Ying and Rosén, Hanna and Johnsson, Ellinor and Calafat, Jero and Tapper, Hans and Olsson, Inge}},
  issn         = {{1528-0020}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{682--688}},
  publisher    = {{American Society of Hematology}},
  series       = {{Blood}},
  title        = {{Sorting of soluble TNF-receptor for granule storage in hematopoietic cells as a principle for targeting of selected proteins to inflamed sites.}},
  url          = {{http://dx.doi.org/10.1182/blood-2002-10-3055}},
  doi          = {{10.1182/blood-2002-10-3055}},
  volume       = {{102}},
  year         = {{2003}},
}